Player FM - Internet Radio Done Right
25 subscribers
Checked 5M ago
Ajouté il y a neuf ans
Contenu fourni par Real Chemistry. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Real Chemistry ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
Player FM - Application Podcast
Mettez-vous hors ligne avec l'application Player FM !
Mettez-vous hors ligne avec l'application Player FM !
Podcasts qui valent la peine d'être écoutés
SPONSORISÉ
S
Species Unite


1 Amber Canavan: The Labels That Lie 30:34
30:34
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé30:34
“That is no life for these birds and it is definitely not what the consumer is thinking or assuming. When they see these nice labels and they think, ‘oh, I'm paying so much more for this, that change must be going for the animals, right?’ No, it's lining the pockets and it's keeping that status quo of that factory farm going.” Amber Canavan Most of us want to make choices that are kinder—to animals, to the planet, to ourselves. But in today’s food system, kindness is often buried under labels like “cage free,” “humane certified,” or even “climate-friendly beef.” These terms are designed to make us feel good, but as PETA’s Amber Canavan reveals, they hide the same suffering and environmental destruction. For more than a decade, Amber has led campaigns that expose this “humane washing” and push companies—from Starbucks to Whole Foods—to do better. This conversation is about pulling back the curtain on the myths we’ve been sold, and about the power each of us has to choose differently. One of the simplest, most impactful ways to take action is with what’s on our plate. That’s why, this October, we’re inviting you to join Species Unite’s Plant-Powered Challenge—a 30-day adventure to try delicious, cruelty-free food, reduce your climate footprint, and stand with the animals. Because real change doesn’t come from labels. It comes from us.…
The Real Chemistry Podcast
Tout marquer comme (non) lu
Manage series 1395881
Contenu fourni par Real Chemistry. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Real Chemistry ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
Modern medicine is advancing at faster speeds than ever before, yet the world still sees the healthcare experience as difficult and dated. The Real Chemistry Podcast shares interviews with industry leaders who are innovating in healthcare. Join Real Chemistry’s Chief Marketing Officer Aaron Strout as he explores how AI and ideas can come together to transform healthcare into what it should be.
…
continue reading
243 episodes
Tout marquer comme (non) lu
Manage series 1395881
Contenu fourni par Real Chemistry. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Real Chemistry ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
Modern medicine is advancing at faster speeds than ever before, yet the world still sees the healthcare experience as difficult and dated. The Real Chemistry Podcast shares interviews with industry leaders who are innovating in healthcare. Join Real Chemistry’s Chief Marketing Officer Aaron Strout as he explores how AI and ideas can come together to transform healthcare into what it should be.
…
continue reading
243 episodes
Tous les épisodes
×
1 The Big C in Cancer Care: Culture - Live from SXSW 2025 42:03
42:03
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé42:03
Discover how personalized treatments crafted with cultural sensitivity and cutting-edge science can enhance patient outcomes and how collaborations in tech and advocacy can pave the way for earlier, more effective cancer interventions.

1 Gen AI in Healthcare: Preserving the Human Touch - Live from SXSW 2025 44:30
44:30
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé44:30
Explore the delicate balance between technological efficiency and the personal touch crucial in health experiences. Panelists will discuss the innovative approaches they’re taking to synergize human empathy with AI to create hyper-personalized communications that respect individual preferences and cultural contexts.…

1 Health Citizenship and the Evolution of Technology and Healthcare: Jane Sarasohn-Kahn, Health Economist 41:16
41:16
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé41:16
A health economist, blogger, two-time author, and keynote speaker, Jane Sarasohn-Kahn is a renowned leader in the healthcare space. On this episode, she discusses health citizenship, its potential impact on the upcoming election, the continuous evolution of technology and healthcare, and what she’s most looking forward to in the future.…

1 Embracing the Power of RNAi Therapeutics: Akshay Vaishnaw, Alnylam Pharmaceuticals 35:37
35:37
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé35:37
Discover the cutting-edge world of RNA interference (RNAi) therapeutics with Dr. Akshay Vaishnaw, Chief Innovation Officer at Alnylam Pharmaceuticals. In this episode, Dr. Vaishnaw sheds light on the groundbreaking concept of RNAi therapeutics, offering a powerful new approach to treating a wide range of diseases. Learn how Alnylam Pharmaceuticals is revolutionizing healthcare with its unwavering commitment to innovation, despite facing numerous setbacks and challenges along the way.…

1 Cannesplaining Healthcare: Creating Award-Worthy Work through Insight and Originality 39:00
39:00
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé39:00
Want to know what it takes to create award-winning work in healthcare advertising? Check out our final Cannesplaining Healthcare podcast episode, live from the 2024 Cannes Lions International Festival of Creativity, featuring our 21GRAMS, a part of Real Chemistry, creative leaders as they explore the intersection of creativity, marketing and healthcare. Discover how to make your health advertising stand out with insights from Real Chemistry Chief Creative Officer & 21GRAMS Managing Founder Frank Mazzola, 21GRAMS Executive Creative Director Lauren Polina, Chief Creative Officer Tom Richards and Executive Creative Director Chris Charles.…

1 Cannesplaining Healthcare: Emphasizing the Importance of Creativity in Healthcare with Genentech Chief Marketing Officer, Dr. Erica Taylor 40:45
40:45
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé40:45
Live from the 2024 Cannes Lions International Festival of Creativity, join us as we explore the intersection of creativity, marketing and healthcare during our latest Cannesplaining Healthcare podcast episode featuring Genentech Chief Marketing Officer (CMO) Dr. Erica Taylor, 21GRAMS Managing Founder & Real Chemistry Chief Creative Officer Frank Mazzola, and 21GRAMS Executive Creative Director Lauren Pollina. Discover how Genentech is modernizing marketing in the pharmaceutical industry and gain insights into the importance of creativity, the challenge of incorporating levity into health marketing and the value of early regulatory involvement in marketing campaigns. Learn from Dr. Erica Taylor's unique journey to her role as CMO and explore the evolving nature of marketing in healthcare.…

1 Cannesplaining Healthcare: Improving Patient Experiences Through Creativity & Innovation With President of Cannes Lions 2024 Pharma Jury, Collette Douaihy 30:07
30:07
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé30:07
Live from the 2024 Cannes Lions International Festival of Creativity, join us for a discussion on the future of healthcare innovation and creativity. In this episode, Collette Douaihy, Dentsu Health Global CCO and President of Cannes Lions 2024 Pharma Jury, 21GRAMS Global CCO Tom Richards and 21GRAMS Executive Creative Director Chris Charles delve into the importance of patient-centricity, building strong client relationships and the ethical use of AI in healthcare. Discover insights on how to create impactful work and stay ahead in the ever-evolving healthcare landscape.…

1 The Art & Science of Cancer Care: A Holistic Approach 44:25
44:25
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé44:25
In the lead up to ASCO 2024, we hosted a discussion on the dynamic landscape of oncology today, looking through the lens of this year’s meeting theme: the art and science of cancer care. Within two featured mini panels, we reviewed key trends and innovations and highlighted how intersections between art and science can help us change the face and future of the cancer experience. Touching on areas like advocacy, AI, screening and therapeutic advances, this can’t miss conversation will help us envision a more effective and compassionate future in oncology. The Art: The art of improving patient care. How industry collaborations, data-based messaging and campaigns and advocacy are helping to reach more patients earlier and more holistically. Ysabel Duron, Founder, President / Executive Director, The Latino Cancer Institute Meredith Owen, Chief Revenue Officer, Analytics & Insights Group, Real Chemistry Shanthi Sivendran, MD, MSCR, MBA, Senior Vice President, Cancer Care Support, American Cancer Society Jewel Jones, Global Inclusion & Health Equity Practice Leader, Real Chemistry The Science: The latest therapeutics advancements in oncology. How technology is helping industry better engage providers and democratize science via visualization to help improve outcomes. HP Balaji, Senior Medical Director and TA Head, Bladder Cancer, Johnson & Johnson Innovative Medicine Brandon Pletsch, President, Scientific Visualization and Exhibit Experience, Real Chemistry…

1 Fighting Health Worker Burnout with Privacy-Safe AI: Live from SXSW 2024 43:50
43:50
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé43:50
Health worker burnout is soaring. A global shortage of providers, an aging population and more complicated Medicare requirements, has increased stress and exhaustion for HCPs. Innovative solutions are needed to ensure high-quality patient care and a sustainable health system. This panel will discuss how AI is helping alleviate pressure on providers while still prioritizing patient privacy and safety. From summarizing journals, to asking an AI agent about dosing or side effects, AI is removing friction so health workers can handle complex engagements, listening, and building relationships.…

1 Cancer 2034: Innovations That Are Shaping the Face of Cancer - Live from SXSW 2024 44:53
44:53
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé44:53
With innovative new approaches to diagnosis and treatment in oncology, the cancer mortality rate has dropped year over year for the last decade. But there is still work to be done, especially as we see increasing cancer incidence among certain populations. But what work is happening today that will shape the face of cancer and the patient experience in the future? Wendy Short Bartie (Bristol Myers Squibb), Maimah Karmo (Tigerlily Foundation), and Emily Poe (Real Chemistry) bring together a tapestry of perspectives, from advocacy and equity, research, prevention and holistic care to envision the next 10 years of progress in cancer.…

1 Partnering to Unlock Hope for the Future of Cancer Care: Live from SXSW 2024 41:54
41:54
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé41:54
While there is undeniable hope for the future of cancer care, systemic barriers still impact access for many patients – particularly those in underserved communities. This session, originally recorded in front of a live audience at SXSW 2024, examines how increasing collaboration and partnerships among organizations that touch all aspects of the cancer journey and reach patients, providers and treatment centers, is critical to expanding access to optimal cancer care and making the goals of the “Cancer Moonshot” a reality. Hear from City of Hope, American Society of Clinical Oncology (ASCO), and American Cancer Society (ACS) about how they are approaching partnerships to create a future where every cancer patient has access to the care they need.…

1 Advancing Medical Communications by Combining Data, Creativity and Human Expertise: Suzanne Jacobs, Real Chemistry & Trina Stonner, Avant Healthcare 29:31
29:31
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé29:31
In this episode, Suzanne Jacobs, Group President of Medical at Real Chemistry, and Trina Stonner, President of Avant Healthcare, discuss Real Chemistry’s newly announced acquisition of Avant Healthcare, how the two companies came together and have similar ethos of supporting physicians in advancing patient care, and how the future of medical communications will involve a combination of data, creativity, AI, and human expertise.…

1 Caregiving and Cancer Prevention: Dr. Karen Knudsen, The American Cancer Society & Jim Weiss, Real Chemistry 37:19
37:19
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé37:19
It's time to talk about cancer prevention and early detection. Join us as we explore the importance of early detection and prevention in the fight against cancer with Dr. Karen Knudsen, CEO of the American Cancer Society, and Jim Weiss, Founder and Chairman at Real Chemistry. Tune in to learn about the role of the American Cancer Society in research, advocacy and patient support, the importance of genetic testing in understanding cancer risk and the future of cancer testing and the role of AI.…

1 Using Generative AI to Bring New Perspectives to Medical Problem Solving: Peter Lee, Microsoft & Brandon Pletsch, Real Chemistry 45:08
45:08
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé45:08
Listen to our latest podcast with Peter Lee, C orporate Vice President, Microsoft Research & Incubations, and Brandon Pletsch, Practice Leader of Scientific Visualization at Real Chemistry, to learn about the applications and implications of generative AI, specifically GPT-4, in healthcare and other fields. They explore public perceptions of AI, its potential benefits and risks, the importance of ethical considerations and regulatory guidelines, and the concept of equitable access to AI in healthcare. Check out the episode to gain insight into how AI can revolutionize fields outside of human language and thought.…

1 Enhancing Healthcare Consistency Through AI: Ajit Singh, Artiman Ventures 40:58
40:58
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé40:58
In this episode, Ajit Singh, PhD, Managing Director and General Partner at Artiman Ventures, shares his insights on various aspects of healthcare, his approach to leadership and decision-making and his thoughts on the future of healthcare. From AI to oncology to neuro technology, Ajit covers it all.
T
The Real Chemistry Podcast

1 Reshaping the Medical Communications World through AI: Jason Gardner, SVP, Head of Medical, Real Chemistry 20:57
20:57
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé20:57
Learn more about the inspiring journey of Jason Gardner, Head of Medical at Real Chemistry, and his views on AI and DE&I in healthcare. From his father's struggle with multiple sclerosis to his strategic approach to medical communications, Jason shares his unique perspectives on how diverse thinking and experiences can bring value to the healthcare industry.…
T
The Real Chemistry Podcast

1 Requiring Transparency and Value-Based Care in the Pharmaceutical Industry: John O'Brien, National Pharmaceutical Council 47:55
47:55
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé47:55
In this episode, National Pharmaceutical Council (NPC) President and CEO John O'Brien, PharmD, MPH, joins Real Chemistry’s Founder and Chairman, Jim Weiss, to discuss the pharmaceutical industry, the value assessment of medicines, the role of government in drug pricing and the importance of research in healthcare policy. Tune in to get the latest insights on the lack of clarity in government guidelines, the hostile environment for the pharmaceutical industry, the shift in benefits and the rise in patient costs, and the need for more transparency and value-based care.…
T
The Real Chemistry Podcast

1 Tackling Health Disinformation in the AI and Digital Age: Dr. Geeta Nayyar, Author, Dead Wrong 27:08
27:08
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé27:08
Misinformation in the digital age is a complex problem, but it can be addressed. In this episode, Dr. Geeta Nayyar, former Chief Medical Officer at Salesforce and AT&T, discusses her book, Dead Wrong, and the role of artificial intelligence in healthcare. Tune in to learn more about the importance of trust in the healthcare industry, the role of life sciences companies in combating misinformation and the necessity of health literacy and prevention.…
T
The Real Chemistry Podcast

1 Valuing Empathy to Ensure Patient-Centered Healthcare Strategies: Javeria Shahab, 21GRAMS, a part of Real Chemistry 31:32
31:32
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé31:32
In this episode, Javeria Shahab, President of Medical Education at 21GRAMS, a part of Real Chemistry, discusses the challenges and changes in the medical education industry, building effective teams and the importance of empathy in healthcare communications. Get an insider's look into the industry and hear Javeria's advice for those looking to break into the field.…
T
The Real Chemistry Podcast

1 Informing Public Health Decisions with Data and Science: Sue Desmond-Hellmann, M.D., Council of Advisors on Science and Technology 55:24
55:24
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé55:24
In this episode, Dr. Sue Desmond-Hellmann, Member of President Biden’s Council of Advisors on Science and Technology and former CEO of the Bill & Melinda Gates Foundation, Mike Huckman, Global Practice Leader of Executive Communications at Real Chemistry, and Jim Weiss, Founder and Chairman at Real Chemistry, discuss the importance of vaccination, the evolution of cancer treatments and the challenges of clinical trials. They also highlight the need for diverse representation in clinical trials, the implications of the Inflation Reduction Act on the pharmaceutical industry and the influence of science in public health and policymaking.…
T
The Real Chemistry Podcast

1 Pioneering Public-Private Partnerships to Tackle Complex Health Issues: Dr. Julie Gerberding, FNIH, Dr. Jay Bradner, FNIH & Jim Weiss, Real Chemistry 55:09
55:09
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé55:09
In this episode, Dr. Julie Gerberding, President and CEO of the Foundation for the National Institutes of Health (FNIH), Dr. Jay Bradner, FNIH board member and former President of the Novartis Institutes for Biomedical Research, and Jim Weiss, Founder and Chairman at Real Chemistry and FNIH board member, discuss the power of collaboration, how trust in science is essential for progress, emerging areas in medicine and the challenges of the current healthcare landscape. Listen to the full episode to gain valuable insights and to learn how FNIH is pioneering public-private partnerships to tackle complex health issues.…
T
The Real Chemistry Podcast

1 Analyzing the Impact of Data and Technology on Healthcare Commercialization: Mark Martin, Houlihan Lokey & Jim Weiss, Real Chemistry 37:46
37:46
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé37:46
In this episode, Mark Martin, Managing Director at Houlihan Lokey, and Jim Weiss, Founder and Chairman at Real Chemistry, explore the healthcare marketing and commercialization industry , including the impact of data and technology, trends in acquisitions and deals, and the importance of organic growth and innovation.…
T
The Real Chemistry Podcast

1 Developing Innovative Digital Medicine Solutions that Address Real Pain Points: Jennifer Goldsack, Digital Medicine Society 40:16
40:16
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé40:16
Digital medicine is essential for improving healthcare and addressing issues related to access and equity. In the latest episode, learn about the importance of digital medicine, the challenges and opportunities in the industry and the importance of an integrated evidence plan. Plus, CEO and Co-Founder of the Digital Medicine Society (DiMe), Jennifer Goldsack, shares her thoughts on generative AI and advice for young professionals in healthcare. As part of DiMe’s upcoming Integrated Evidence Plans for Digital Health Products (IEP) project, leaders in digital health product development, regulation, reimbursement and commercial strategy will partner with payers, purchasers, policymakers, clinicians and patient groups to identify core components of an integrated evidence plan. If you would like to engage in this project and help streamline the path to regulatory and commercial success to optimize health outcomes for the greatest number of patients, learn more and share your interest to join ( https://dimesociety.org/access-resources/evidence-defined/#iep-form ).…
T
The Real Chemistry Podcast

1 Addressing Liver Health through Collaboration and Innovation: Donna Cryer, Global Liver Institute 32:37
32:37
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé32:37
Did you know that there are more than 100 types of liver diseases that affect 1.5 billion people worldwide? Join us as we explore the importance of collaboration and innovation in addressing liver health issues, the role of digital health and equity, and the future of liver health with Donna Cryer, J.D., Founder, President and CEO of the Global Liver Institute. Get the inside scoop on the latest developments in the field of liver health and how they can improve patient outcomes and access to care.…
T
The Real Chemistry Podcast

1 Exploring Space as the Next Frontier for Biopharma R&D: Maureen Haverty, Seraphim Space/Generation Space 29:53
29:53
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé29:53
Space exploration and research are rapidly advancing, and life sciences is a key component of this progress. Learn more about the opportunities and developments in space R&D and manufacturing, particularly in the life sciences sector, from Maureen Haverty, VP of Investment at Seraphim Space/Generation Space.…
T
The Real Chemistry Podcast

1 Transforming How Patients Manage Chronic Conditions: Waqaas Al-Siddiq, Biotricity 25:45
25:45
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé25:45
In this episode with Biotricity CEO and Founder Waqaas Al-Siddiq, PhD, discover how AI is transforming healthcare and how Biotricity's Bioheart device is helping to manage and prevent cardiac conditions.
T
The Real Chemistry Podcast

1 Using Effective Communication to Build Strong Bridges: Sally Susman, Pfizer & Jim Weiss, Real Chemistry 49:11
49:11
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé49:11
Communication is a critical skill for leaders and company culture. In this episode, Real Chemistry Founder and Chairman Jim Weiss is joined by Sally Susman, Chief Corporate Affairs Officer of Pfizer and author of "Breaking Through," who shares her insights on the importance of communication in leadership, building corporate and product brands, and navigating challenging conversations.…
T
The Real Chemistry Podcast

1 Delivering Personalized Care for Chronic Health Conditions: Live from SXSW 2023 with Lee Shapiro 27:31
27:31
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé27:31
Recorded live from SXSW 2023, 7wire Ventures Co-Founder & Managing Partner Lee Shapiro explores how technology, data and collaboration can be used to make healthcare more personalized, efficient and cost-effective, ultimately leading to improved health outcomes.
T
The Real Chemistry Podcast

1 Generative AI: Oh God What Now?: Live from SXSW 2023 33:49
33:49
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé33:49
With tools like ChatGPT and DALL-E dominating news cycles, many people – especially those working in creative jobs – are wondering if they will soon be replaced by the technology known as generative AI. During this session, originally recorded in front of a live audience at SXSW 2023, Sameer Grover, CNS Sr. Specialty Division Manager at AbbVie, and Romain Bogaerts, Director of AI Product Management at Real Chemistry, discuss what impact generative AI is having on the creative process, particularly in the healthcare space. Who is using generative AI, and where do we see things headed over the next 6-12 months (or weeks?)…
T
The Real Chemistry Podcast

1 Becoming a Change Agent through Impactful Disruption: Live from SXSW 2023 with GSK’s Alison Woo 26:11
26:11
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé26:11
Recorded live from SXSW 2023, Alison Woo, Head of Strategy, Planning and Paid Campaigns, Communications & Government Affairs at GSK, shares what a day in her life looks like, what she gathered at SXSW this year and what it means to be disruptive at a company without being too disruptive.
T
The Real Chemistry Podcast

1 A Day in the Life of a Biopharmaceutical Leader: Live from SXSW 2023 42:12
42:12
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé42:12
This presentation, originally recorded in front of a live audience at SXSW 2023, showcases key stories and perspectives on what a day in the life of a leader at Bristol-Myers Squibb looks like. From their experiences and challenges to how their focus on patients drives them to continue to strive in their role during these truly complicated times. Panelists: Dr. Rosanna Ricafort, Vice President, Cell Therapy Clinical Development, Bristol-Myers Squibb Bryant Powell, Associate Director & Chief of Staff, Bristol-Myers Squibb (Co-moderator) Aaron Strout, Chief Marketing Officer, Real Chemistry (Co-moderator)…
T
The Real Chemistry Podcast

1 Innovating Data Approaches for Clinical Trial Recruitment: Live from SXSW 2023 47:15
47:15
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé47:15
This panel, originally recorded in front of a live audience at SXSW 2023, discusses innovative data sources for clinical trial recruitment and how to maximize their effectiveness. The panel explores a range of innovative data sources, such as online platforms, real world data and social networks, and how they can be used to find the right candidates for a study. The panelists discuss the advantages and disadvantages of different data sources, such as the potential cost savings, access to a larger pool of potential participants and the ability to target specific populations. They also discuss potential ethical considerations, such as protecting participant privacy and ensuring that the data used is accurate and up-to-date. Panelists Bryan Hansen, Director of Data Science & Digital Health Neuroscience, Johnson & Johnson Maimah Karmo, CEO & President, Tigerlily Foundation Joan Severson, Chief Innovation Officer, Clinical Ink Aaron Strout, Chief Marketing Officer, Real Chemistry (Host)…
T
The Real Chemistry Podcast

1 Understanding Trends to Shape our Future Normal: Rohit Bhargava, Founder & Chief Trend Curator, Non-Obvious Company 28:52
28:52
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé28:52
Recorded live from SXSW 2023, Founder & Chief Trend Curator of the Non-Obvious Company Rohit Bhargava joins us to discuss why he continues to come back to SXSW, how the event has evolved and his new book co-authored with Henry Coutinho-Mason, The Future Normal , which leans into healthcare trends.…
T
The Real Chemistry Podcast

1 Changing the Relationship of Underserved Populations with Clinical Trials: Dr. Keolu Fox, Co-Founder, Native BioData Consortium & Assistant Professor, University of California, San Diego 34:24
34:24
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé34:24
Indigenous futurist and technologist Dr. Keolu Fox joins us this week to discuss how increased diversity in clinical trials can transform healthcare for underserved populations and for the overall healthcare system.
T
The Real Chemistry Podcast

1 Building a Community of Caregivers: Andrew Parker, CEO & Founder, Papa 33:24
33:24
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé33:24
This week, CEO & Founder of Papa Andrew Parker joins the podcast and discusses how his company is empowering a new kind of healthcare built on human connection. Papa, a platform that connects older adults with Pals who provide companionship and assistance, seeks to address the caregiving shortage and support the US healthcare system’s Triple Aim.…
T
The Real Chemistry Podcast

1 Addressing a New Wave of Healthcare Challenges: Annalisa Jenkins, Compass Pathways & Jim Weiss, Real Chemistry 38:35
38:35
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé38:35
Annalisa Jenkins, MBBS, Non Executive Director at Compass Pathways & Jim Weiss, Founder and Chairman at Real Chemistry, join the podcast this week to discuss women in life sciences leadership roles, novel approaches to disease areas such as infectious diseases and cancer, and using AI for a more effective healthcare system.…
T
The Real Chemistry Podcast

1 Breaking Down Healthcare Industry Barriers: Chas Bountra, PhD, Pro Vice-Chancellor for Innovation & Professor for Translational Medicine, University of Oxford & Jim Weiss, Founder & CEO, Real… 36:34
36:34
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé36:34
Chas Bountra, PhD, Pro Vice-Chancellor for Innovation & Professor for Translational Medicine at the University of Oxford, and Jim Weiss, Founder & CEO of Real Chemistry, join this week’s episode to discuss accelerating healthcare through novel ideas and the importance of collaborating across organizations, industries and countries.…
T
The Real Chemistry Podcast

1 Democratizing Access to Healthcare: Pranam Ben, Founder & CEO, The Garage 28:23
28:23
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé28:23
Founder and CEO of The Garage, Pranam Ben, joins us to discuss the future of value-based care and The Garage’s approach of using technology and data to solve for equity and access issues facing the healthcare industry. Read The Garage’s blog post, Tiny Tasty Morsels , to learn about their Quintuple Aim approach to change healthcare for good.…
T
The Real Chemistry Podcast

1 Building the Future of HEOR: Christopher Boone, PhD, VP & Global Head of HEOR, AbbVie 29:23
29:23
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé29:23
In this week’s episode, Christopher Boone, PhD, VP & Global Head of Health Economic Outcomes and Research (HEOR) at AbbVie, discusses the changing landscape of HEOR, the importance of leadership, collaboration and innovation in the pharmaceutical industry, and the story behind his Twitter handle, DataHippie.…
T
The Real Chemistry Podcast

1 Improving Patient Care through Better Data Interoperability: Frank Harvey, CEO, Surescripts 18:18
18:18
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé18:18
In this week’s episode, Surescripts CEO Frank Harvey discusses how Surescripts is improving healthcare data interoperability and better empowering pharmacists to provide primary care to patients.
T
The Real Chemistry Podcast

1 Harnessing the Human Approach: Harpreet Sood, MD, VP, Primary Care & Clinical Partnerships, Huma 25:48
25:48
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé25:48
Huma VP of Primary Care & Clinical Partnerships Harpreet Sood, MD discusses shifts in the digital health market and how Huma differentiates itself through a focus on patient centricity and collaboration across healthcare systems and teams.
T
The Real Chemistry Podcast

1 Simplifying Medicine with Technology: Matt Titus, VP & Chief Commercial Officer, epocrates 21:28
21:28
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé21:28
Data and technology should make physicians’ lives simpler, not more complicated. Matt Titus, VP & Chief Commercial Officer, epocrates, shares how his team is making an impact.
T
The Real Chemistry Podcast

1 Advocating for Patients: Elle Cole, Founder of Cleverly Changing, Patient Advocate & Author 16:01
16:01
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé16:01
Working toward creating better patient outcomes and experiences is something we have in common with Elle Cole, Founder of Cleverly Changing, Patient Advocate & Author.
T
The Real Chemistry Podcast

1 Assessing the State of COVID-19: Monica Gandhi MD, MPH, Professor of Medicine, UCSF 32:25
32:25
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé32:25
The doctor will see you now! Monica Gandhi, MD, MPH, Professor of Medicine, UCSF, is back on the show, and she’s talking about all things COVID-19, flu, and vaccines.
T
The Real Chemistry Podcast

1 Investing in Marketing & Analytics: Mark Stouse, Chairman & CEO, Proof 27:22
27:22
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé27:22
Investing in marketing and analytics is critical to navigating your organization successfully. Mark Stouse, Chairman & CEO of Proof, and Jim Weiss, Founder & Chairman of Real Chemistry, join the show to discuss this and the current state of marketing.
Bienvenue sur Lecteur FM!
Lecteur FM recherche sur Internet des podcasts de haute qualité que vous pourrez apprécier dès maintenant. C'est la meilleure application de podcast et fonctionne sur Android, iPhone et le Web. Inscrivez-vous pour synchroniser les abonnements sur tous les appareils.